APA

Engineer R., Mohandas K. M., Shukla P. J., Shrikhande S. V., Mahantshetty U., Chopra S., Goel M., Mehta S., Patil P., Ramadwar M., Deodhar K., Arya S. & Shrivastava S. K. (20140226). Escalated radiation dose alone vs. concurrent chemoradiation for locally advanced and unresectable rectal cancers: results from phase II randomized study. : International journal of colorectal disease.

Chicago

Engineer Reena, Mohandas K M, Shukla P J, Shrikhande S V, Mahantshetty U, Chopra S, Goel M, Mehta S, Patil P, Ramadwar M, Deodhar K, Arya S and Shrivastava Shyam Kishore. 20140226. Escalated radiation dose alone vs. concurrent chemoradiation for locally advanced and unresectable rectal cancers: results from phase II randomized study. : International journal of colorectal disease.

Harvard

Engineer R., Mohandas K. M., Shukla P. J., Shrikhande S. V., Mahantshetty U., Chopra S., Goel M., Mehta S., Patil P., Ramadwar M., Deodhar K., Arya S. and Shrivastava S. K. (20140226). Escalated radiation dose alone vs. concurrent chemoradiation for locally advanced and unresectable rectal cancers: results from phase II randomized study. : International journal of colorectal disease.

MLA

Engineer Reena, Mohandas K M, Shukla P J, Shrikhande S V, Mahantshetty U, Chopra S, Goel M, Mehta S, Patil P, Ramadwar M, Deodhar K, Arya S and Shrivastava Shyam Kishore. Escalated radiation dose alone vs. concurrent chemoradiation for locally advanced and unresectable rectal cancers: results from phase II randomized study. : International journal of colorectal disease. 20140226.